Clinical Trial Update: A Study of Avoralstat In Participants With Diabetic Macular Edema [Phase 1]

View source ↗

Summary

This update describes a Phase 1 study of Avoralstat in participants with Diabetic Macular Edema, and the trial is currently active but not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetic Macular Edema

Drugs mentioned

• Avoralstat (avoralstat)

Snippet

Sponsor: BioCryst Pharmaceuticals | Conditions: Diabetic Macular Edema (DME) | Phase 1 | Status: ACTIVE_NOT_RECRUITING